<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

SmartTRAK Spotlight: SUTUREGARD Medical

Posted by Don Urbanowicz on 1/16/19 10:13 AM

SUTUREGARD is on a mission to close more wounds simply and safely

SmartTRAK Spotlights SUTUREGARD medical, a privately held medical device firm with patented technology that allows surgeons to perform simple closures of high-tension wounds through rapid intraoperative tissue expansion.

Company Overview

Founded in 2015 and based in Portland, Oregon, SUTUREGARD™ Medical, Inc. is a privately held medical device firm with patented technology that allows surgeons to perform simple closures of high-tension wounds through rapid intraoperative tissue expansion. For skin cancer surgeons (Mohs Surgeons), SUTUREGARD’s initial target market, the SUTUREGARD™ device allows closure of wounds using tissue expansion instead of relying on flaps, grafts, or second intent healing. This is particularly useful for scalp and lower leg closures. For some skin cancer surgeons, this will add greater efficiency to their day. For other skin cancer surgeons, this will retain closures in their practice that they would have otherwise sent to other specialists.

The Company founders — a Corvallis, Oregon-based skin cancer (Moh’s) surgeon and his Ph.D. nurse business partner — designed the SUTUREGARD device. The Company invested three years conducting bench research, pre-clinical studies, and customer discovery prior to completion of a successful human use study in 2018.

“SUTUREGARD Medical launched the SUTUREGARD device in November, 2018 at the Fundamentals of Mohs Surgery Conference and the product was enthusiastically received by surgeons.”   Dan Ladizinsky, MD, CEO of SUTUREGARD Medical.

Read More

Topics: Advanced Wound Care

Q318 Advanced Wound Care Market Recap: All Segments Showing Softness

Posted by Susan Paquette on 12/13/18 1:54 PM

All segments showing softness, lowest quarterly growth rate since 2015

For Q318, according to BioMedGPS’ SmartTRAK Financial Dashboard, WW Advanced Wound Care (AWC) revenues for Advanced Dressings, External Devices and Biologics was up +3.0% YoY, with Acelity, also known as KCI, maintaining its leadership position with estimated Q318 revenues of...

Read More

Topics: Advanced Wound Care, Q318 Market Recaps

Preventing Peripheral IV Failure: The Next Big Thing

Posted by Susan Paquette on 11/26/18 4:21 PM

Products that prevent peripheral IV failures could be the next big thing in the market for vascular access adjunct products, a market opportunity valued at more than $600MM in the US alone, according to SmartTRAK estimates.

All eyes were on the high failure rate of peripheral IVs at the Association of Vascular Access (AVA) 2018 Annual Scientific Meeting, with speakers highlighting the 2015 article by Helm et al. “Accepted but Unacceptable: Peripheral IV Catheter Failure,” which estimates a PIV failure rate of 35% to 50% primarily caused by phlebitis, infiltration, occlusion/mechanical failure, dislodgment and infection. Failure is defined as the removal of the catheter prior to the end of its intended life or before the 72 to 96 hours previously used as a guideline. And with up to 90% of all hospitalized patients receiving a PIV, it is a standard but often overlooked procedure in the hospital.

The primary emphasis over the last 10 to 15 years has been the reduction of catheter-related bloodstream infections (CRBSIs) associated with central line catheters. Driving this focus has been CMS reimbursement penalties for hospital acquired central line bloodstream infections (CLABSIs). This new focus on PIVs could be exciting for manufacturers, especially those with adjunct vascular access products. Clinicians insert approximately 250 million PIVs every year in the US (assuming a 25% failure rate on first insertion), a market that is 25 times larger than the US market for central line catheters...

Download the "Next Big Thing in Vascular Access" article now...

Read More

Topics: Advanced Wound Care, Vascular

SmartTRAK Attending SAWC Fall in Las Vegas

Posted by Susan Paquette on 10/29/18 4:33 PM

SmartTRAK is excited to be attending SAWC Fall 2018 on November 2-4 at Caesars Palace in Las Vegas.

Susan Paquette, VP & GM Wound, BioMedGPS and Geoffrey Brown, Director Corporate Accounts, Wound Care will be there representing SmartTRAK. Please contact us if you would like to meet. 

Read More

Topics: Advanced Wound Care, SmartTRAK Conferences

Q218 Advanced Wound Care Market Recap

Posted by Susan Paquette on 9/26/18 10:39 AM

All segments experiencing modest growth of +4% to +5%: advanced dressings recovering, biologics slowing down, and single-use boosting NPWT.

For Q218, according to BioMedGPS’ SmartTRAK Financial Dashboard, WW Advanced Wound Care (AWC) revenues for Advanced Dressings, External Devices and Biologics grew +4.7% compared to Q217.

Among the many topics covered in detail in the comprehensive Q218 Advanced Wound Care Market Recap are:

Read More

Topics: Advanced Wound Care

SmartTRAK Publication Alert: Q118 Advanced Wound Care Market Recap

Posted by Susan Paquette on 6/20/18 9:01 AM

SmartTRAK, the leading source of competitive life sciences intelligence used by the top ten global orthopedic & wound care companies, has published its Q118 Advanced Wound Care Market Recap.

Read More

Topics: Advanced Wound Care

SmartTRAK Cited in SastoMed EWMA Wound Care Innovation Award

Posted by Susan Paquette on 5/23/18 11:38 AM

Susan Paquette, VP & General Manager Wound at SmartTRAK, was quoted in the press release announcing the 3rd Annual Advanced Wound Care Innovation Award presented to SastoMed GmbH by Alira Health and the European Wound Management Association (EWMA) on May 18, 2018, for their hemoglobin-based wound spray, which can be used easily in everyday wound healing treatment as an adjunct to the current standard of care. 

Read More

Topics: Advanced Wound Care

SmartTRAK Presents at EWMA 2018 AWC Symposium

Posted by Susan Paquette on 5/9/18 9:41 AM

Susan Paquette, SmartTRAK's VP and GM for the Wound segment, will be presenting an overview of the European Advanced Wound Care market at the Advanced Wound Care Innovation Symposium Expert Panel Discussion 2018 on May 10th at EWMA 2018 in Krakow, Poland.

Susan attended EWMA 2017 in Amsterdam and posted this analysis "
Read More

Topics: Advanced Wound Care, SmartTRAK Conferences

SmartTRAK Participating in AWC Symposium at EWMA 2018

Posted by Susan Paquette on 5/2/18 11:50 AM

SmartTRAK will be attending EWMA 2018 - the European Wound Management Association Conference, May 9-11 in Krakow, Poland.

SmartTRAK's Susan Paquette, VP and GM, Wound, will be representing SmartTRAK at the Advanced Wound Care Innovation Symposium Expert Panel Discussion on May 10th, giving  an overview of the European Advanced Wound Care market. Also attending the conference for SmartTRAK is Lennart Stadler, Senior Analyst, Wound Care.
Read More

Topics: Advanced Wound Care, SmartTRAK Conferences

SmartTRAK Presents two New Modules at SAWC Spring 2018

Posted by Susan Paquette on 4/30/18 4:42 PM

 SmartTRAK Life Sciences Business Intelligence is proud to announce the addition of two new Wound Care modules, EU NPWT and China Advanced Dressings, to the extensive list of Wound Care market segments now available on SmartTRAK, featuring in-depth analysis, daily updates and strategic insights.

 

 

 

Read More

Topics: Advanced Wound Care, SmartTRAK Conferences

Subscribe to News and Analysis Blog Weekly Emails

SmartTRAK is the leading source of competitive intelligence used by the top ten global orthopedic and wound care companies. 

Recent Posts